Close
  Indian J Med Microbiol
 

Figure 3: Microscopic evaluation of cultivation (a) osteosarcoma-Mesenchymal stem cells only (b) osteosarcoma-Mesenchymal stem cells co-cultivated with Peripheral blood mononuclear cells (c) osteosarcoma-Mesenchymal stem cells co-cultivated with Peripheral blood mononuclear cell sensitized with secretome (d) osteosarcoma-Mesenchymal stem cells co-cultivated with Peripheral blood mononuclear cell sensitized with granulocyte macrophage colony stimulating factor (e) osteosarcoma-Mesenchymal stem cells co-cultivated with Peripheral blood mononuclear cell activated using granulocyte macrophage colony stimulating factor and secretome (f) Interleukin-2 levels in osteosarcoma-Mesenchymal stem cells co-cultivated with Peripheral blood mononuclear cells sensitized by secretome, granulocyte macrophage colony stimulating factor, and combination

Figure 3: Microscopic evaluation of cultivation (a) osteosarcoma-Mesenchymal stem cells only (b) osteosarcoma-Mesenchymal stem cells co-cultivated with Peripheral blood mononuclear cells (c) osteosarcoma-Mesenchymal stem cells co-cultivated with Peripheral blood mononuclear cell sensitized with secretome (d) osteosarcoma-Mesenchymal stem cells co-cultivated with Peripheral blood mononuclear cell sensitized with granulocyte macrophage colony stimulating factor (e) osteosarcoma-Mesenchymal stem cells co-cultivated with Peripheral blood mononuclear cell activated using granulocyte macrophage colony stimulating factor and secretome (f) Interleukin-2 levels in osteosarcoma-Mesenchymal stem cells co-cultivated with Peripheral blood mononuclear cells sensitized by secretome, granulocyte macrophage colony stimulating factor, and combination